Impact of ischemic risk factors on long-term outcomes in patients with and without high bleeding risk

Yuki Shima(Kurashiki Central Hospital), Kazushige Kadota(Kurashiki Central Hospital), Syunsuke Kubo(Kurashiki Central Hospital), Takenobu Shimada(Osaka Metropolitan University), Yasushi Fuku(Kurashiki Central Hospital), Katsuya Miura(Kurashiki Central Hospital), Hiroyuki Tanaka(Kurashiki Central Hospital), Ryosuke Murai(Shiga University of Medical Science), Takeshi Tada(Kurashiki Central Hospital), Masanobu Ohya(Kurashiki Central Hospital)
International Journal of Cardiology
November 2, 2020
10.1016/j.ijcard.2020.10.073
Cited by 4

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
|Circulation|2009|358
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
|JAMA Cardiology|2022|313
Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent
|Journal of the American College of Cardiology|2013|204
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
|Journal of the American Heart Association|2018|198